aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 3.97 USD -0.5% Market Closed
Market Cap: 333.2m USD

Intrinsic Value

ATYR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ATYR stock under the Base Case scenario is 4.23 USD. Compared to the current market price of 3.97 USD, aTyr Pharma Inc is Undervalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ATYR Intrinsic Value
4.23 USD
Undervaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
aTyr Pharma Inc

ATYR
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ATYR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

aTyr Pharma Inc
NASDAQ:ATYR
US
Biotechnology
Market Cap
333.2m USD
IPO
May 7, 2015
US
Biotechnology
Market Cap
333.2m USD
IPO
May 7, 2015
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ATYR?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about aTyr Pharma Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
aTyr Pharma Inc

Current Assets 76.3m
Cash & Short-Term Investments 66m
Receivables 1.8m
Other Current Assets 8.5m
Non-Current Assets 15.3m
PP&E 12.2m
Other Non-Current Assets 3.1m
Efficiency

Free Cash Flow Analysis
aTyr Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
aTyr Pharma Inc

Revenue
235k USD
Operating Expenses
-68.3m USD
Operating Income
-68.1m USD
Other Expenses
4.2m USD
Net Income
-63.8m USD
Fundamental Scores

ATYR Profitability Score
Profitability Due Diligence

aTyr Pharma Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
ROIC is Increasing
Negative 1-Year Revenue Growth
Declining ROE
16/100
Profitability
Score

aTyr Pharma Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

ATYR Solvency Score
Solvency Due Diligence

aTyr Pharma Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
54/100
Solvency
Score

aTyr Pharma Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ATYR Price Targets Summary
aTyr Pharma Inc

Wall Street analysts forecast ATYR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATYR is 18.76 USD with a low forecast of 9.09 USD and a high forecast of 36.75 USD.

Lowest
Price Target
9.09 USD
129% Upside
Average
Price Target
18.76 USD
372% Upside
Highest
Price Target
36.75 USD
826% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

aTyr Pharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ATYR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ATYR Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ATYR stock?

The intrinsic value of one ATYR stock under the Base Case scenario is 4.23 USD.

Is ATYR stock undervalued or overvalued?

Compared to the current market price of 3.97 USD, aTyr Pharma Inc is Undervalued by 6%.

Back to Top